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Background: Tuberculosis (TB) is a major public health concern in the developing world. Early diagnosis and
prompt initiation of treatment is essential for effective TB control. The aim of this study was to determine the
length and analyze associated factors of patients’ and health system’s delays in the diagnosis and treatment of new
pulmonary TB (PTB) patients.
Methods: A cross-sectional study was conducted in 30 randomly selected public health facilities in West Gojjam
Zone, Amhara Region, Ethiopia. Newly diagnosed PTB patients who were ≥15 years of age were consecutively
enrolled in the study. Patients’ delay (the time period from onset of TB symptoms to first presentation to a formal
health provider) and health system’s delay (the time period from first presentation to a formal health provider to
first start of TB treatment) were measured. Median patients’ and health system’s delays were calculated. Mixed
effect logistic regression was used to analyze predictors of patients’ and health system’s delays.
Results: Seven hundred six patients were enrolled in the study. The median patients’ delay was 18 days
(interquartile range [IQR]: 8–34 days) and the median health system’s delay was 22 days (IQR: 4–88 days). Poor
knowledge of TB (adjusted odds ratio [AOR], 2.33; 95 % confidence interval [CI], 1.34–4.05), first visit to non-formal
health provider (AOR, 47.56; 95 % CI, 26.31–85.99), self-treatment (AOR, 10.11; 95 % CI, 4.53–22.56) and patients’ age
(≥45 years) (AOR, 2.99; 95 % CI, 1.14–7.81) were independent predictors of patients’ delay. Smear-negative TB (AOR,
1.88; 95 % CI, 1.32–2.68) and first visit to public health centers (AOR, 2.22; 95 % CI, 1.52–3.25) and health posts (AOR,
5.86; 95 % CI, 1.40–24.39) were found to be independent predictors of health system’s delay.
Conclusions: The health system’s delay in this study was long and contributed more than 50 % of the total delay.
Better TB diagnostic tools to complement sputum smear microscopy are needed to early diagnose PTB cases at
peripheral health facilities. In addition, due emphasis should be given to increase public awareness about
symptoms and consequences of TB disease.
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Tuberculosis (TB) is a major public health concern in
the developing world. According to a recent World
Health Organization (WHO) report, there were 9.6 mil-
lion new TB cases and 1.5 million deaths from TB
worldwide [1]. The 22 high TB burden countries collect-
ively accounted for 80 % of all estimated incident cases.
Ethiopia is among the 22 high-TB burden countries in
the world. The directly observed treatment short-course
strategy (DOTS) has been adopted in the country since
1992 to control the TB epidemic [2]. The prevalence, in-
cidence and mortality from all forms of TB in Ethiopia
is currently estimated at 200/100,000 population, 207/
100,000 population and 33 per 100,000 population, re-
spectively [1]. These indicators show that the TB burden
in Ethiopia is still enormous.
Early diagnosis and prompt initiation of treatment is
an essential intervention to significantly reduce the TB
burden. Diagnostic and treatment delays contribute to
increased TB transmission and severity of illness [3].
Delay in diagnosis and treatment of TB has been studied
in various parts of the world. A systematic review re-
ported that the median time of delay from onset of
cough until treatment initiation varied from 21 to 136
days [4]. A number of socio-demographic, economic, be-
havioral and clinical parameters were identified as fac-
tors associated with diagnostic delay [4].
Reports of earlier studies from different regions of
Ethiopia showed median patients’ and health system’s
delays ranging from 20 to 63 days and 6 to 42 days, re-
spectively [5–15]. Various factors including rural resi-
dence [9, 11, 12], being smear-positive PTB case [9],
being illiterate [9, 11, 14], being extra pulmonary TB
(EPTB) case [12, 14], old age [6] and first visit to non-
formal health provider [10–12, 14] were identified as
predictors of long patients’ delay. On the other hand,
first visit to health centers, health posts, clinics and pri-
vate health facilities [10, 12], being EPTB case [8, 10]
and far distance from health facilities [5] were associated
with increased health system’s delay.
In Amhara Region where the current study was con-
ducted, few studies assessed patients’ and health system’s
delays [6, 12, 14, 15]. However, most of these studies
[12, 14, 15] were done at health facilities found in the
capital city of Amhara Region, Bahir Dar and did not
consider peripheral health facilities. Only one study that
was conducted in a comparable setting with the current
study investigated diagnostic and treatment delay by in-
cluding health institutions found in both rural and urban
areas in Amhara Region [6]. However, the study subjects
who were included in that study were only smear-
positive cases, indicating the need for more studies.
The length and factors associated with patients’ and
health system’s delays may greatly vary across differentpopulation, socio-economic conditions, culture and geo-
graphical settings. West Gojjam zone is one of the zones
in the Amhara Region of Ethiopia where the highest
number of TB cases were reported in 2013 [16]. None-
theless, there is no study that addressed the magnitude
and associated factors of patients’ and health system’s
delays in this zone. Understanding the extent and factors
associated with patients’ and health system’s delays in
high TB burden settings helps to improve TB case detec-
tion, treatment and ultimately reduce the TB incidence.
The aim of this study was to determine the length and
analyze factors associated with patients’ and health sys-




This study was conducted in West Gojjam Zone which
is one of the ten zones of Amhara Region, Ethiopia. The
total population is estimated at 2 382 497 [17]. More
than 90 % of the population resides in rural areas, and
agriculture is the main source of livelihood for the com-
munity. During the study period, one government hos-
pital, 90 government health centers, 356 health posts
and 76 private health institutions were rendering health
services to the population. A health post is the lowest
level health care and is staffed by two female health ex-
tension workers (HEWs). HEWs play an important role
in identifying and referring TB suspects to the next level
of health care i.e. health centers for TB diagnosis and
initiation of treatment. Health posts are not equipped
with TB diagnostic tools. Sputum smear microscopy is
the only TB diagnostic tool for PTB patients attending
majority of the health centers. Thus, clinically suspected
smear-negative PTB cases are referred to hospitals and
private health facilities for chest radiography and other
tests for TB.
Sampling technique
Random sampling method was used to select study sites.
First, we obtained list of all public health facilities pro-
viding TB diagnostic and treatment services in West
Gojjam Zone. Accordingly, 73 health centers and one
hospital were providing TB diagnostic and treatment
services during the study period. Of these, 29 health
centers were randomly selected. We also added one hos-
pital, which is the only available hospital in the study
zone. This makes a total of 30 study sites. The private
health facilities were not included in this study.
Study design, population and data collection
This was a health facility based cross-sectional study
conducted in 30 public health facilities in West Gojjam
Zone from Oct 2013 to Oct 2014. All newly diagnosed
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sites were consecutively enrolled in the study. Partici-
pants were interviewed at the time of treatment initi-
ation during the study period. PTB patients below
15 years of age, EPTB patients, and patients with MDR-
TB and a previous history of TB were excluded from the
study.
Socio-demographic and clinical data were collected
using a pre-tested semi-structured questionnaire. The
data among others included, age, sex, place of residence,
symptoms at presentation, human immunodeficiency
virus (HIV) sero-status, knowledge of TB, time period
between onset of TB suggestive symptoms (i.e. cough,
haemoptysis, weight loss, night sweats and fever) and
first visit to formal-health provider, and time period be-
tween first visit to formal health provider and first start
of treatment. Trained health officers and nurses at each
study site collected the data. To assure quality of the
data, frequent supervision was made by the principal in-
vestigator and other supervisors throughout the data
collection period. Diagnosis of TB was based on the na-
tional TB diagnosis algorism [18]. Smear-positive PTB is
diagnosed when a patient has at least two initial sputum
smear examinations positive for acid-fast bacilli (AFB),
or one initial smear examination positive for AFB and
culture positive, or one initial smear examination posi-
tive for AFB and radiographic abnormalities consistent
with active TB. Smear-negative PTB is diagnosed when a
patient has symptoms suggestive of TB with at least
three initial sputum smear examinations negative for
AFB, radiographic abnormalities consistent with active
PTB, no response to a course of broad spectrum antibi-
otics and a decision by a clinician to treat with a full
course of anti-TB chemotherapy. Provider initiated HIV
counseling and testing service is one of the routine clin-
ical services given to TB patients.
Sample size was determined using the formula for esti-
mating single population proportion. Therefore, by tak-
ing 48 % proportion of delay of more than 1 month
from a previous study in Amhara Region [6], a margin
error of 4 %, 95 % CI and 10 % non-response rate, the
total sample size was estimated at 659. However, we in-
cluded all of the 706 new PTB patients that attended the
study sites during the study period. This accounted for
107 % of the minimum sample size required for the study.Operational definition of variables
A new case of TB is a patient who has never had treat-
ment for TB or who had taken anti-TB drugs for less
than 1 month.
Formal-health providers: modern health care facilities
such as health posts, clinics, health centers and hospitals
owned by the government or the private sector.Non-formal health providers: include traditional health
care providers and drug retail outlets.
Patients’ delay: the time period from onset of TB
symptoms till first presentation to a formal- health
provider.
Long patients’ delay: if the time period from the onset
of TB symptoms to first presentation to a formal health
provider exceeds more than 30 days.
Health system’s delay: the time period from first pres-
entation to a formal health provider to first start of anti-
TB treatment.
Long health system’s delay: if the time period from
first presentation to a formal health provider to first
start of anti-TB treatment exceeds more than 15 days.
Diagnostic delay: the time period from onset of TB
symptoms to first diagnosis of TB.
Total delay: the time period from onset of TB symp-
toms to first start of anti-TB treatment.Statistical analysis
Data were entered, cleaned and analyzed using Statistical
Package for the Social Sciences (SPSS) IBM Version 22
(SPSS Inc. Chicago, IL, USA). Descriptive statistics such
as proportions, medians with IQR were computed. As
the data were skewed, non-parametric tests (Mann–
Whitney/Kruskal-Wallis) were employed to compare
group differences in patients’ and health system’s delays.
Mann–Whitney test was used to compare two groups
and the Kruskal-Wallis test was used for comparing
three or more groups. Based on experiences from previ-
ous studies, 30 days cut-off point was used to
dichotomize patients’ delay into “delayed” and “non-de-
layed” patient groups [6, 12]. Likewise, 15 days cut-off
point was applied to dichotomize health system’s delay
into “delayed” and “non-delayed” patient groups [6, 12].
For each TB knowledge question, a score of one was
given for the correct answer and a zero score was given
for incorrect responses. Then, total knowledge score and
median were calculated. Finally, those with a total score
of below the median value were classified as having poor
knowledge whereas, those equal or above the median
value were considered as having good knowledge. To as-
sess if patients felt perceived stigma due to TB, patients
were asked a question related to TB related stigma.
Those who answered yes were classified as having per-
ceived stigma to TB whereas; those who answered no
were classified as not having felt perceived stigma to TB.
In order to adjust the clustering effect and analyze the
independent effects of each exposure variables on pa-
tients’ and health system’s delays, mixed-effect logistic
regression model was used. Health facilities were held as
random effect variable and other predictor variables
were used as fixed effect.
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tic regression model, the Intra-class Correlation Coeffi-
cient (ICC) was calculated in the empty model and it
was indicated that 0.149 (14.9 %) of the total variance in
health system delay was attributable to the differences
across health facilities. The test of the preference of log
likelihood Vs logistic regression was strongly significant
(P < 0.001). Likewise, 0.043 (4 %) of the total variance in
patients’ delay was attributable to the differences across
health facilities. The test of the preference of log likeli-
hood Vs logistic regression was significant (P = 0.01).
Then, the full model was run by including health facil-
ities as a random effect variable and other predictor vari-
ables as fixed effects and the (ICC) became 0.176
indicating that 17.6 % of the variation in health system’s
delay was attributed to cluster level. The preference of
log likelihood Vs logistic regression was still strongly sig-
nificant (P < 0.001). Similarly, for the patients’ delay after
the full model run the ICC was 0.062 indicating that
10.0 % of the variation in patients’ delay was attributed
to cluster level. The preference of log likelihood Vs logistic
regression was significant (P =0.05).
Univariate and multivariate analysis were performed
using STATA V.14 (College station, TX USA). Variables
found to be statistically significant in the bivariate ana-
lysis were included in multivariate model. In addition,
variables that showed a p value of > 0.05 but were clinic-
ally or epidemiologically relevant for the analysis were
included in the multivariate model. Crude odds ratio
(COR) and AOR with 95 % CI were used to assess the
degree of association between predictors and dependent
variables. A p-value of less than 0.05 was considered sta-
tistically significant.
Results
Characteristics of the study subjects
A total of 706 new PTB patients were included in the
study, and of these were 334 (47.3 %) sputum smear-
positive and 372 (52.7 %) sputum smear-negative pa-
tients. The median age of the study participants was
30 years (IQR: 23–47 years), and 423 (59.9 %) were
males. Nearly 62 % (435) of the study subjects reside in
rural areas. More than 58 % (411) of patients had no for-
mal education and 327 (46.3 %) were farmers by occupa-
tion. Majority, 95 % (671) of the study participants
reported to have taken less than two hours to reach at
the nearest health facility (Table 1).
TB symptoms and first health care seeking action
Majority, 97.9 % (619) of the patients had persistent
cough. Other symptoms reported were: loss of appetite
633 (89.7 %), chest pain 578 (81.9 %), night sweats 569
(80.6 %), body weight loss 548 (77.6 %), fever 513
(72.7 %) and hemoptysis 167 (23.7 %).Four hundred and thirty three (61.3 %) patients first
sought health care from formal-health providers. Two
hundred twenty three (31.6 %) patients initially sought
health care from non-formal health providers. Among
these, 112 (15.9 %) used holy water, 102 (14.4 %) visited
drug retail outlets and 9 (1.3 %) sought treatment from
traditional healers. The remaining 50 (7.1 %) patients
first practiced self-treatment using various remedies at
their homes. Among patients who first sought health
care from formal-health providers, 236 (54.5 %) patients
had no formal education. On the other hand, 175
(64.1 %) patients who first sought health care from
non-formal health providers had no formal education
(P < 0.01).Types of formal-health providers where all patients made
their first consultation
Patients had reported the types of health facilities where
they first sought health care. Accordingly, 342 (48.4 %),
71 (10 %), 13 (2 %) and 280 (39.6 %) initially visited pub-
lic health centers, public hospitals, public health posts
and private health facilities, respectively.Patients’ delay
The median patients’ delay was 18 days (IQR: 8–34 days).
The median patients’ delay for those patients who first
visited non-formal health providers, formal-health pro-
viders, and those who first practiced self-treatment with
various remedies at their home were 60 days, 14 days
and 22 days, respectively (Kruskal-Wallis test; p < 0.001)
(Table 2), (Fig. 1). Of the total study participants, 512
(72.5 %) patients visited formal-health providers within
30 days following the onset of symptoms. Of the study
participants who first visited formal-health providers
within 30 days after the onset of symptoms, 219 (42.8 %)
had poor knowledge of TB compared to 136 (70.1 %) pa-
tients who first visited formal-health providers after
30 days of onset of symptoms and had poor knowledge
of TB (P < 0.001).
In the multivariate analysis, patients who first visited
non-formal health providers and those who first prac-
ticed self-treatment with various remedies at their home
were more likely to experience longer patients’ delay
compared to patients who first visited formal-health pro-
viders (AOR, 47.56; 95 % CI, 26.31–85.99) and (AOR,
10.11; 95 % CI, 4.53–22.56), respectively. Being in the
age group ≥ 45 years, and those patients who had poor
knowledge of TB were more likely to experience longer
patients’ delay compared to the younger age group and
patients with good knowledge of TB (AOR, 2.99; 95 % CI,
1.14–7.81) and (AOR, 2.33; 95 % CI, 1.34–4.05),
respectively (Table 3).
Table 1 Socio-demographic and clinical characteristics of the
study participants, West Gojjam Zone, Ethiopia
























Day laborer 82 11.6
Merchant 47 6.7
Others 94 13.3
Monthly family income (Birr) a
1–400 109 15.4
401–800 84 11.9
≥ 801 264 37.4




Not known 8 1.1
Time travelled to arrive at the nearest health facility
≤ 2 h 671 95
> 2 h 35 5
Perceived to be stigmatized
Yes 88 12.5
No 618 87.5
Table 1 Socio-demographic and clinical characteristics of the





Smear-positive PTB 334 47.3
Smear-negative PTB 372 52.7
a 1 USD = 22.00 Ethiopian Birr
PTB pulmonary tuberculosis
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The median health system’s delay was 22 days (IQR: 4–
88 days). The health system’s delay for 394 (55.8 %)
study participants was more than 15 days. In bivariate
analysis, smear-negative patients had longer health sys-
tem’s delay than smear-positive patients: 27 days versus
15 days, respectively (Mann–Whitney test, P < 0.001)
(Table 2), (Fig. 2).
In multivariate analysis, smear-negative patients were
more likely to experience longer health system’s delay
than smear-positive patients (AOR, 1.88; 95 % CI, 1.32–
2.68). Patients who first visited public health centers and
health posts were more likely to experience longer
health system’s delay compared to patients who first vis-
ited private health institutions (AOR, 2.22; 95 % CI,
1.52–3.25) (AOR, 5.86; 95 % CI, 1.40–24.39), respect-
ively. Patients who were housewife by occupation were
less likely to experience longer health system’s delay
compared to civil servants (AOR, 0.10; 95 % CI, 0.02–
0.40) (Table 4).
Total delay
The median total delay was 60 days. Health system’s
delay contributed the largest portion of the total delay.
Discussion
In this study, the health system’s delay contributed more
than 50 % of the total delay. Interventions that may re-
duce health system’s delay have been put in place in the
study area. TB screening activities have been integrated
with the general health service in health care facilities.
According to the national TB control guideline [18], pa-
tients presenting with cough of more than 2 weeks are
subjected to smear microscopy examination for AFB.
This strategy helps to minimize missed opportunities for
early diagnosis and treatment initiation for TB patients
[19]. In addition, the DOTS strategy has been decentra-
lized, making TB diagnostic and treatment services more
accessible to the community. Increased health services
accessibility reduces both patients’ [20, 21] and health
system’s delays [5]. Despite the integration of TB screen-
ing activities in the general health care and increased
Table 2 Patients’ and health system’s delays of new PTB patients by background characterstics, West Gojjam Zone, Ethiopia
Variables N Patients’ delay (days) Health system’s delay (days)
Median IQR P value Median IQR P value
Age (years) < 0.001* 0.55
15–24 197 15.0 7–29 20.0 5–69
25–44 291 17.0 7–31 21.0 5–81
≥ 45 218 22.0 12–51 29.0 4–114
Sex 0.33 0.95
Male 423 17.0 8–30 22.0 4–95
Female 283 19.0 8–45 23.0 4–81
Place of residence 0.001* 0.32
Urban 271 15.0 7–30 19 4–76
Rural 435 20.0 9–45 25 4–100
Educational level < 0.001* 0.37
Not literate 411 21.0 12–55 26.0 4–109
Literate 295 15.0 7–25 20.0 5–61
Marital status 0.03* 0.58
Married 386 20.0 10–35 22.0 4–95
Single 205 15.0 7–30 20.0 5–69
Divorced 73 21.0 8–60 32.0 5–124
Widowed 42 21.0 11–56 25.0 7–89
Occupation 0.01* 0.71
Civil servant 41 7.0 5–15 24 6–49
Housewife 39 21.0 7–60 7 3–27
Student 76 15.0 7–30 19 4–58
Farmer 327 20.0 9–40 26 4–113
Day laborer 82 20.0 14–31 24 4–77
Merchant 47 15.0 10–22 14 4–89
Others 94 16.0 7–36 27 7–94
Monthly family income (Birr) a 0.35 0.22*
1–400 109 20.0 11–31 8.0 3–56
401–800 84 19.0 11–62 22.0 5–78
≥ 801 264 18.0 7–31 27.0 4–113
No regular income 249 16.0 7–36 24.0 4–73
HIV sero-status 0.68 0.31
Positive 82 20.0 11–45 22.0 5–86
Negative 616 18.0 8–33 22.0 4–88
Not known 8 16.0 7–29 74.0 8–320
Time travelled to the nearest health facility 0.08 0.96
≤ 2 h 671 17.0 8–31 23 4–88
> 2 h 35 23.0 14–70 15 4–106
Perceived to be stigmatized 0.47 0.70
Yes 88 18.0 8–31 19.0 4–87
No 618 19.5 10–39 23.0 4–88
Gebreegziabher et al. BMC Infectious Diseases  (2016) 16:673 Page 6 of 13
Table 2 Patients’ and health system’s delays of new PTB patients by background characterstics, West Gojjam Zone, Ethiopia
(Continued)
knowledge about TB < 0.001* 0.14
Good 351 15.0 7–25 18.0 5–61
Poor 355 23.0 14–60 28.0 4–113
Types of PTB 0.23 < 0.001*
Smear-positive PTB 334 16.0 8–31 15 3–76
Smear-negative PTB 372 19.0 7–39 27 7–95
First health care seeking action < 0.001* 0.12
Visited formal health providers 433 14 7–21 24 5–93
Visited non -formal health providers 223 60 24–116 15 4–86
Self-treatment using various remedies at home 50 21.5 15–60 27 4–85
Type of formal health provider first visited 0.81 0.02*
Private health facilities 280 20 8–31 15 4–70
Public health centers 342 15 7–37 31 5–97
Public hospitals 71 18 10–41 15 4–86
Health posts 13 15 8–30 29 10–203
Note: using non-parametric Kruskal-Wallis test to compare three or more groups and Mann–Whitney test to compare two groups * statistically significant. IQR inter
quartile range, PTB pulmonary tuberculosis, HIV human immunodeficiency virus
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it is surprising that the median health system’s delay ob-
served in the current study is still similar with findings
of former studies conducted in Amhara Region of
Ethiopia [6, 12]. In a recent qualitative study [22], a
number of challenges that may have implications for in-
creased health system’s delay were reported from the
study area. Among others, frequent interruptions of la-
boratory reagents and anti-TB drugs supplies, lack of
diagnostic tools for smear-negative TB and lack of la-
boratory personnel in some health centers were identi-
fied as challenges of the TB control program [22].
Interventions directed at solving these challenges areFig. 1 Kaplan-Meier survival estimate by first health care seeking
action. Note: Patients’ delay is defined as the time period from
onset of symptoms till first presentation to a formal-health provider.
The graph describes patients’ delay by first visit to formal health
provider, non-formal health provider and first practiced self-treatment
with various remedies at their homeessential to reduce the long health system’s delay
observed in the study area.
Studies in other regions of Ethiopia (Addis Ababa [5],
Southern Region [13]) showed shorter median health
system’s delay compared to the current study result. This
may be due to the differences in study settings. The
studies in Addis Ababa and Southern Region of Ethiopia
were conducted in urban setting where better diagnostic
facilities and experienced health care providers are avail-
able. The median health system’s delay in our study is
also higher than findings of similar studies done in
other African countries such as Angola [23] and
Zimbabwe [24].
The median patients’ delay observed in this study is
18 days. This is shorter than the findings of former stud-
ies conducted in comparable settings in Amhara Region
(median patients’ delay 30 days) [6, 7]. It is also shorter
compared to findings of similar studies from other re-
gions of Ethiopia: Addis Ababa (median patients’ delay
60 days [5], Tigray (median patients’ delay 30 days) [9]
and Southern Region (median patients’ delay 30 days)
[13]. The median patients’ delay in this study is compar-
able with findings of former studies from other countries
such as Malawi (median patients’ delay 14 days) [21] and
India (median patients’ delay 15 days) [25]. The discrep-
ancies in the study findings might be related to differ-
ences in study settings, sample sizes used, socio-cultural
and socio-demographic factors, definitions and cut-off
points used to measure the delay periods and study time
periods. The relatively shorter median patients’ delay
observed in our study may be related to improved access
to TB diagnostic and treatment services as a









Male 423 103 (24.3) 1.00 1.00
Female 283 91 (32.2) 1.54 (1.09–2.19) 0.01* 1.25 (0.72–2.15) 0.43
Age
15–24 197 39 (19.8) 1.00 1.00
25–44 291 77 (26.5) 1.45 (0.93–2.28) 0.09 2.27 (0.96–5.38) 0.06
≥ 45 218 78 (35.8) 2.30 (1.45–3.64) < 0.001* 2.99 (1.14–7.81) 0.03*
Education
Literate 295 55 (18.6) 1.00 1.00
Not literate 411 139 (33.8) 2. 22 (1.54–3.21) < 0.001* 0.87 (0.44–1.72) 0.69
Occupation
Civil servant 41 3 (7.3) 1.00 1.00
Housewife 39 14 (35.9) 7.16 (1.82–28.08) 0.01* 1.04 (0.13–8.29) 0.97
Student 76 18 (23.7) 4.33 (1.16–16.06) 0.03* 1.09 (0.15–7.75) 0.93
Farmer 327 102 (31.2) 5.82 (1.73–19.61) 0.01* 0.87 (0.17–4.32) 0.87
Day laborer 82 21 (25.6) 4.46 (1.22–16.24) 0.02* 0.61 (0.98–3.78) 0.59
Merchant 47 9 (19.1) 2.97 (0.72–12.11) 0.13 0.58 (0.90–3.74) 0.57
Others 94 27 (28.7) 5.46 (1.52–19.57) 0.01* 0.65 (0.99–4.33) 0.66
Marital status
Married 386 109 (28.2) 1.00 1.00
Single 205 44 (21.5) 0.72 (0.47–1.08) 0.12 1.02 (0.44–2.33) 0.96
Divorced 73 24 (32.9) 1.27 (0.73–2.21) 0.39 1.23 (0.52–2.88) 0.64
Widowed 42 17 (40.5) 1.92 (0.97–3.81) 0.06 2.01 (0.68–5.90) 0.20
Place of residence
Urban 271 59 (21.8) 1.00 1.00
Rural 435 135 (31.0) 1.61 (1.11–2.33) 0.01* 1.60 (0.87–2.94) 0.13
Monthly family income (Birr) a
1–400 109 30 (27.5) 0.96 (0.57–1.63) 0.91 0.82 (0.27–2.45) 0.73
401–800 84 28 (33.3) 1.22 (0.71–2.13) 0.46 0.76 (0.23–2.56) 0.66
≥ 801 264 67 (25.4) 0.82 (0.54–1.24) 0.36 0.61 (0.19–1.89) 0.39
No regular income 249 69 (27.7) 1.00 1.00
HIV sero-status
Negative 616 169 (27.4) 1.00 1.00
Positive 82 24 (29.3) 1.06 (0.63–1.79) 0.82 0.76 (0.34–1.71) 0.52
knowledge about TB
Good 351 58 (16.5) 1.00 1.00
Poor 355 136 (38.3) 3.39 (2.33–4.95) < 0.001* 2.33 (1.34–4.05) 0.01*
Perceived to be stigmatized
No 618 167 (27.0) 1.00 1.00
Yes 88 27 (30.7) 1.18 (0.71–1.98) 0.51 1.37 (0.66–2.84) 0.39
Time travelled to arrive at the nearest health facility
≤ 2 h 671 181 (27.0) 1.00 1.00
> 2 h 35 13 (37.1) 1.64 (0.78–3.43) 0.18 0.65 (0.23–1.79) 0.40
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Table 3 Associations of socio demographic and clinical factors with patients’ delay among PTB patients, West Gojjam Zone, Ethiopia
(Continued)
First health care seeking action
Visited formal health provider 433 24 (5.5) 1.00 1.00
Visited non-formal health provider 223 152 (68.2) 39.73 (23.39–67.48) < 0.001* 47.56 (26.31–85.99) < 0.001*
Self-treatment using various remedies at their homes 50 18 (36.0) 9.97 (4.79–20.76) < 0.001* 10.11 (4.53–22.56) < 0.001*
Types of PTB
Smear -positive PTB 334 84 (25.1) 1.00 1.00
Smear -negative PTB 372 110 (29.6) 1.30 (0.93–1.84) 0.13 1.32 (0.81–2.16) 0.26
Estimated for random effect =0.384 (0.197–0 .746)
¶ Delayed more than 30 days, a 1 USD = 22.00 Ethiopian Birr *statistically significant association, PTB pulmonary tuberculosis, N number, OR odds ratio, CI
confidence interval
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be linked to the increasing involvement of HEWs in
identifying and referring TB suspects to the nearest
health facilities where AFB smear microscopy test is
available.
More than half of the study participants (72.5 %)
sought health care from formal-health providers within
30 days following the onset of TB symptoms. In a previ-
ous study conducted in a comparable setting in Amhara
Region, 52 % of the study participants visited formal-
health providers within 30 days [6]. This may indicate
patients increased preference to formal-health providers
for health seeking.
The health system’s delay for 394 (55.8 %) study par-
ticipants exceeded 15 days. Patients who first consulted
public health centers experienced longer health system’s
delay compared to those who first visited private health
facilities. This is in line with other study findings in
Ethiopia [10] and Malawi [21]. On the other hand, lon-
ger health system’s delay among TB patients who first
visited private medical providers than those whoFig. 2 Kaplan-Meier survival estimate by TB type. Note: Health
system’s delay defined as the time period from first presentation to
a formal health provider to first start of anti-TB treatment. The graph
describes health system’s delay by type of TBconsulted public health center was reported in a study
conducted in Amhara Region, Ethiopia [6]. This differ-
ence may be related to the increasing involvement of
private health facilities in TB care in the last 6 years in
the study region.
The long health system’s delay observed among pa-
tients who first visited public health centers in the
current study may be due to lack of better TB diagnostic
tools at health centers. Smear microscopy is the only TB
diagnostic tool used in majority of health centers of the
study area during the study period. Smear microscopy
has very low sensitivity [27] and many patients can get
false negative results. The long health system’s delay
may also be related to less experienced health providers
particularly working at peripheral health centers [22].
Thus TB patients may require to make repeated visits
before they are diagnosed and started on treatment. A
previous systematic review indicated that the problem of
delay in diagnosis and treatment of TB is a vicious cycle
of repeated visits at the same health care level [4].
First vist to health posts was also identified as a factor
for longer health system’s delay. This is similar with
findings of previous studies done in Ethiopia [6, 10]. The
finding can be explained by the fact that health posts are
not equipped with diagnostic facilities for TB. Health
posts are run by HEWs whose roles are limited to iden-
tifying and referring TB suspects to the nearest health
centers where smear microscopy test for TB is available.
Being a smear-negative TB case is another factor asso-
ciated with health system’s delay. Similar findings were
observed in other countries [21, 28]. Diagnosis of PTB
in the study zone is based on the national TB diagnostic
and treatment guideline [18]. According to the guideline,
PTB suspects with smear-negative TB are first treated
with non-specific broad-spectrum antibiotics for 7-10
days duration. Subsequently, patients will be re-
examined within 2-4 weeks before they are started on
anti-TB drugs. This indicates that the diagnostic process
for smear-negative TB patients may take between 15 and
30 days before anti-TB treatment is initiated. Delay in
Table 4 Associations of sociodemographic and clinical factors with health system’s delay among PTB patients, West Gojjam Zone,
Ethiopia








Male 423 236 (55.8) 1.00 1.00
Female 283 158 (55.8) 1.00 (0.72–1.39) 0.99 1.11 (0.76–1.61) 0.57
Age
15–24 197 110 (55.8) 1.00 1.00
25–44 291 162 (55.7) 0.96 (0.64–1.42) 0.85 0.85 (0.51–1.44) 0.56
≥ 45 218 122 (56.0) 1.03 (0.67–1.58) 0.86 0.85 (0.47–1.53) 0.58
Education
Literate 295 165 (55.9) 1.00 1.00
Not literate 411 229 (55.7) 1.12 (0.81–1.57) 0.47 1.25 (0.78–1.99) 0.35
Occupation
Civil servant 41 25 (61.0) 1.00 1.00
Housewife 39 11 (28.2) 0.21 (0.07–0.58) 0.01* 0.10 (0.02–0.40) 0.01*
Student 76 43 (56.6) 0.77 (0.33–1.82) 0.56 0.39 (0.11–1.35) 0.14
Farmer 327 187 (57.2) 0.89 (0.43–1.85) 0.76 0.85 (0.35–2.04) 0.73
Day laborer 82 47 (57.3) 0.78 (0.34–1.81) 0.57 0.53 (0.17–1.64) 0.27
Merchant 47 22 (46.8) 0.57 (0.22–1.46) 0.24 0.91 (0.32–2.59) 0.86
Other 94 59 (62.8) 1.04 (0.45–2.38) 0.92 0.62 (0.19–2.01) 0.43
Place of residence
Urban 271 144 (53.1) 1.00 1.00
Rural 435 250 (57.5) 1.38 (0.97–1.96) 0.07 1.24 (0.80–1.93) 0.33
Monthly family income (Birr) b
1–400 109 50 (45.9) 0.69 (0.42–1.14) 0.15 0.46 (0.18–1.03) 0.06
401–800 84 43 (51.2) 0.85 (0.49–1.47) 0.57 0.47 (0.19–1.17) 0.11
≥ 801 264 157 (59.5) 1.15 (0.78–1.71) 0.46 0.60 (0.25–1.42) 0.25
No regular income 249 144 (57.8) 1.00 1.00
HIV sero- status
Positive 82 47 (57.3) 1.05 (0.63–1.74) 0.86 1.33 (0.72–2.46) 0.35
Negative 616 342 (55.5) 1.00 1.00
Time travelled to arrive at the nearest health facility
≤ 2 h 671 377 (56.2) 1.00 1.00
> 2 h 35 17 (48.6) 0.85 (0.41–1.78) 0.67 0.68 (0.31–1.51) 0.35
Formal health providers c
Private health facilities 280 137 (48.9) 1.00 1.00
Public health centers 342 213 (62.3) 2.00 (1.40–2.85) < 0.001* 2.22 (1.52–3.25) < 0.001*
Public hospitals 71 34 (47.9) 0.86 (0.48–1.55) 0.63 0.79 (0.43–1.48) 0.47
Health posts 13 10 (76.9) 4.75 (1.17–19.27) 0.03* 5.86 (1.40–24.39) 0.02*
Forms of PTB
Smear-positive PTB 334 166 (49.7) 1.00 1.00
Smear-negative PTB 372 228 (61.3) 1.64 (1.18–2.27) 0.01* 1.88 (1.32–2.68) < 0.001*
Estimated for random effect = 0.702 (0 .337, 0.965)
a Delayed more than 15 days, OR odds ratio, CI confidence interval
b 1 USD = 22.00 Ethiopian Birr *statistically significant association, PTB pulmonary tuberculosis
c Types of formal-health providers where all patients made their first consultation
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tion to TB transmission in the community. Previous
studies from Canada and California demonstrated that
the contribution of patients with smear-negative,
culture-positive TB to TB transmission were 17 % and
22 %, respectively [29, 30]. Based on the national TB
prevalence survey in Ethiopia, 57 % of smear-negative
cases were culture positive [31]. Another study in
Ethiopia documented that 47 % smear-negative cases
were culture positive [32]. This may suggest that availing
better diagnostic tools for health institutions, particularly
at health centers where majority of the TB patients first
seek care expedites timely diagnosis and treatment of
PTB cases.
The level of knowledge about TB was found to be sig-
nificantly associated with patients’ delay. Patients who
had poor knowledge of TB were more likely to have lon-
ger patients’ delay than those who had good knowledge
of TB. This is consistent with findings of previous stud-
ies [8, 9, 21, 33, 34] and may suggest that lack of aware-
ness may lead to patients’ reluctance in seeking
appropriate health care.
A patient with 2 weeks duration of persistent cough is
considered a suspected case of TB [35]. In this study,
nearly 28 % of the study participants made their first
consultation with formal-health providers after staying
more than 30 days following onset of symptoms. This
finding suggests that concerted effort is required to in-
crease public awareness about the importance of early
health care seeking from formal-health providers.
Patients who first visited non-formal health providers
had longer patients’ delay compared to those who first
consulted formal-health providers. This is similar with
findings of previous studies in Ethiopia [10–12, 14] and
other African countries [24, 33]. More than 30 % of pa-
tients initially sought traditional form of health care be-
fore visiting formal health providers. This finding is in
line with previous studies [6, 13]. Our finding may indi-
cate that a substantial proportion of TB patients are still
first using informal treatment for TB symptom manage-
ment. This may have implications on severity of TB,
poor treatment outcome and transmission of TB in the
community. Training non-formal health providers about
TB suspect identification and early referral may contrib-
ute to reduce patients’ delay.
Patients, who first practiced self-treatment with vari-
ous remedies at their home, were more likely to experi-
ence longer patients’ delay than those who first visited
formal-health provides. This is similar with reports of
other studies [6, 10], which might be related to poor
knowledge of TB. Patients in the age group ≥ 45 years
experienced long patients’ delay compared to the youn-
ger age group which is consistent with other studies [6,
24]. Older patients are dependent on others help andmay not early seek health care [12]. In addition, patients
in the older age group usually present with non-specific
symptoms making it difficult to diagnose TB [12, 36].
The reason for the observed lower health system’s delay
among housewives compared to civil servants is not
clear and warrants for further study.
The study has potential limitations. Firstly, it did not
include extra pulmonary and retreatment TB cases. Sec-
ondly, the study was carried out only in government
health facilities. Private health facilities were not in-
cluded. Therefore, the results cannot be generalized to
all TB patients attending public and private health facil-
ities in the study area. Patients may not exactly remem-
ber the onset of their symptoms and is subject to recall
bias. However, efforts were made to reduce recall bias by
using local calendars listing major religious and national
days to define the perceived date of onset TB symptoms.Conclusions
A substantial proportion of PTB patients in this study
were delayed before diagnosis and initiation of treat-
ment. The health system’s delay was long and contrib-
uted more than 50 % of the total delay. Smear-negative
TB, first visit to public health centers and health posts
were predictors for long health system’s delay. Poor
knowledge of TB, patients’ age ≥45 years of age, self-
treatment and first health seeking from informal-health
providers were factors associated with longer patients’
delay. The study highlights the need to enhance TB diag-
nostic capacity of health facilities particularly public
health centers. Better TB diagnostic tool to complement
(AFB) sputum smear microscopy is needed to early diag-
nose PTB cases at peripheral health facilities. In
addition, due emphasis should be given to increase pub-
lic awareness about the symptoms and consequences of
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